Ryan J. Burri

821 total citations
16 papers, 570 citations indexed

About

Ryan J. Burri is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Ryan J. Burri has authored 16 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 5 papers in Radiation and 4 papers in Surgery. Recurrent topics in Ryan J. Burri's work include Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (8 papers) and Advanced Radiotherapy Techniques (5 papers). Ryan J. Burri is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (8 papers) and Advanced Radiotherapy Techniques (5 papers). Ryan J. Burri collaborates with scholars based in United States and Canada. Ryan J. Burri's co-authors include Nelson N. Stone, Richard G. Stock, Jamie A. Cesaretti, Pam Unger, Barry S. Rosenstein, David P. Atencio, Sheila Annie Peters, Christopher A. Peters, Alice Y. Ho and Harry Ostrer and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Ryan J. Burri

16 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan J. Burri United States 12 396 178 145 88 75 16 570
N. Pimentel Portugal 11 227 0.6× 132 0.7× 105 0.7× 99 1.1× 63 0.8× 25 400
Pervin Hürmüz Türkiye 12 239 0.6× 89 0.5× 109 0.8× 61 0.7× 89 1.2× 55 381
Caterina Polli Italy 8 274 0.7× 105 0.6× 107 0.7× 158 1.8× 117 1.6× 9 474
Karin Olson United States 15 384 1.0× 80 0.4× 73 0.5× 262 3.0× 79 1.1× 34 620
Stephen Greco United States 10 227 0.6× 68 0.4× 128 0.9× 60 0.7× 46 0.6× 32 359
Ása Karlsdóttir Norway 16 359 0.9× 258 1.4× 180 1.2× 66 0.8× 282 3.8× 36 668
Shane Mesko United States 12 192 0.5× 119 0.7× 99 0.7× 74 0.8× 79 1.1× 37 368
Tommy Sheu United States 10 194 0.5× 58 0.3× 75 0.5× 134 1.5× 64 0.9× 23 418
Juan Martin Magsanoc United States 5 376 0.9× 158 0.9× 89 0.6× 68 0.8× 155 2.1× 10 461
Tanja Baresic Italy 12 461 1.2× 87 0.5× 281 1.9× 79 0.9× 59 0.8× 20 601

Countries citing papers authored by Ryan J. Burri

Since Specialization
Citations

This map shows the geographic impact of Ryan J. Burri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan J. Burri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan J. Burri more than expected).

Fields of papers citing papers by Ryan J. Burri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan J. Burri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan J. Burri. The network helps show where Ryan J. Burri may publish in the future.

Co-authorship network of co-authors of Ryan J. Burri

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan J. Burri. A scholar is included among the top collaborators of Ryan J. Burri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan J. Burri. Ryan J. Burri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Yamoah, Kosj, Kyung Min Lee, Shivanshu Awasthi, et al.. (2022). Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System. JAMA Network Open. 5(1). e2144027–e2144027. 59 indexed citations
2.
Yamoah, Kosj, Jasreman Dhillon, Peter A.S. Johnstone, et al.. (2021). A prospective validation of the genomic classifier to define high-metastasis risk in a subset of African American men with early localized prostate cancer: VanDAAM study.. Journal of Clinical Oncology. 39(15_suppl). 5005–5005. 1 indexed citations
4.
Horowitz, David P., Balázs Halmos, John M. Poneros, et al.. (2012). Management of Esophageal Squamous Cell Carcinoma with Definitive Chemoradiotherapy in a Patient with Scleroderma: Case Report and Review of the Literature. Journal of Gastrointestinal Cancer. 43(S1). 156–160. 1 indexed citations
5.
Ng, John, Igor Shuryak, Y. Xu, et al.. (2012). Predicting the Risk of Secondary Lung Malignancies Associated With Whole-Breast Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 83(4). 1101–1106. 16 indexed citations
6.
Forsythe, Kevin, Ryan J. Burri, Nelson N. Stone, & Richard G. Stock. (2011). Predictors of Metastatic Disease After Prostate Brachytherapy. International Journal of Radiation Oncology*Biology*Physics. 83(2). 645–652. 9 indexed citations
8.
Burri, Ryan J., Nelson N. Stone, Pam Unger, & Richard G. Stock. (2010). Long-Term Outcome and Toxicity of Salvage Brachytherapy for Local Failure After Initial Radiotherapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 77(5). 1338–1344. 112 indexed citations
9.
Burri, Ryan J., Alice Y. Ho, Kevin Forsythe, et al.. (2010). Young Men Have Equivalent Biochemical Outcomes Compared With Older Men After Treatment With Brachytherapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 77(5). 1315–1321. 36 indexed citations
10.
Ho, Alice Y., Ryan J. Burri, Jamie A. Cesaretti, Nelson N. Stone, & Richard G. Stock. (2009). Radiation Dose Predicts for Biochemical Control in Intermediate-Risk Prostate Cancer Patients Treated With Low-Dose-Rate Brachytherapy. International Journal of Radiation Oncology*Biology*Physics. 75(1). 16–22. 43 indexed citations
11.
Burri, Ryan J. & Nancy Y. Lee. (2009). Concurrent chemotherapy and radiotherapy for head and neck cancer. Expert Review of Anticancer Therapy. 9(3). 293–302. 21 indexed citations
12.
Burri, Ryan J., Richard G. Stock, Jamie A. Cesaretti, et al.. (2008). Association of Single Nucleotide Polymorphisms inSOD2, XRCC1andXRCC3with Susceptibility for the Development of Adverse Effects Resulting from Radiotherapy for Prostate Cancer. Radiation Research. 170(1). 49–59. 74 indexed citations
13.
Burri, Ryan J., Lale Kostakoğlu, Benjamin Hoch, et al.. (2008). Correlation of Positron Emission Tomography Standard Uptake Value and Pathologic Specimen Size in Cancer of the Head and Neck. International Journal of Radiation Oncology*Biology*Physics. 71(3). 682–688. 50 indexed citations
15.
Cesaretti, Jamie A., Richard G. Stock, David P. Atencio, et al.. (2007). A Genetically Determined Dose–Volume Histogram Predicts for Rectal Bleeding among Patients Treated With Prostate Brachytherapy. International Journal of Radiation Oncology*Biology*Physics. 68(5). 1410–1416. 48 indexed citations
16.
Peters, Christopher A., Richard G. Stock, Jamie A. Cesaretti, et al.. (2007). TGFB1 Single Nucleotide Polymorphisms Are Associated With Adverse Quality of Life in Prostate Cancer Patients Treated With Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 70(3). 752–759. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026